Search

Search Constraints

You searched for: Author/Creator Tebbutt, Niall

Search Results

1. Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis. Issue 4 (3rd April 2018)

2. ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours. Issue 1 (December 2016)

3. Impact of geography on prognostic outcomes of 21, 509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis. (June 2021)

4. In colon cancer cells fascin1 regulates adherens junction remodeling. Issue 3 (14th February 2023)

5. Management of early-stage gastro-esophageal cancers: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty. Issue 4 (2nd April 2020)

6. Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials. Issue 2 (26th February 2022)

7. MRI rectal cancer in Australia and New Zealand: An audit from the PETACC‐6 trial. Issue 5 (11th July 2016)

8. Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer. Issue 1 (28th November 2020)

9. Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD. Issue 1 (1st January 2021)

10. Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First‐Line Metastatic Colorectal Cancer. (10th October 2017)